Lung Cancer Screening—Expanded Recommendations! - Frankly Speaking Ep 238

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 AMA PRA Category 1 Credit™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235" target="_blank" rel= "noopener">https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Episode resource links:</p> <ul> <li style="font-family: Calibri; font-size: 11pt;">Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117</li> </ul> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Robert A. Baldor MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>